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Control of translation initiation was recognised as a critical checkpoint for cell proliferation and tumorigenesis. In human
melanoma cells, we have previously reported consistent overexpression of translation initiation factor eIF-4A1. Here, we
investigated by transfection of antisense constructs its signiﬁcance for the control of melanoma cell growth. The tetracycline-
inducible expression system was established in melanoma cells, and three fragments of the 5'-, central-, and 3'-portion of the
eIF-4A1 cDNA were subcloned in antisense and in sense orientation after a tetracycline inducible promoter. Signiﬁcant
proliferation decrease was obtained after transient transfection and induction of antisense RNA directed against the 5'- and
the central portion (up to 10%), whereas, no effects were seen after induction of the 3'-fragment and the sense controls. Cell
clones stably transfected with the central antisense fragment revealed after doxycycline induction reduced expression of
endogeneous eIF-4A1 mRNA correlated with decreased proliferation rates (up to 6%). These data demonstrate the
applicability of antisense strategies against translation factors in melanoma cells. Translation initiation factor eIF-4A1 contributes
to the control of melanoma cell proliferation and may be taken into consideration when scheduling new therapeutic
approaches targeting the translational control.
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Control of protein synthesis is known as a cellular mechanism
important for saving energy resources and for rapidly responding
to changing growth requirements. In recent years more and more
data are emerging on the involvement of this process in cell growth
and in tumorigenesis. It is mainly the initiation of translation,
which turned out to be a checkpoint for cell proliferation.
In eucaryotes, initiation of translation, which brings mRNA and
ribosomal subunits together, is triggered by a number of initiation
factors (eIF). This process may be subdivided into ﬁve steps corre-
sponding to ﬁve groups of translation initiation factors (Rhoads,
1993). The starting point of the initiation process may be seen in
the binding of eIF-2 to the initiator-tRNA and to GTP in a ternary
complex, which subsequently binds the 40S small ribosomal subu-
nit resulting in the 43S pre-initiation complex. In parallel, eIF-4E
binds to the mRNA cap structure as well as to eIF-4G, which itself
is a large polypeptide supplying binding sites for eIF-4A and eIF-3.
This complex enables transient melting of the mRNA secondary
structure to then allow the ribosomal subunit to enter and scan
the mRNA in 3' direction for the initiation codon. For RNA melt-
ing, the helicase activity described for eIF-4A is essential (Ray et al,
1985).
In current therapeutic strategies against cancer less interest has
been focussed on protein synthesis mechanisms. However, an
increasing body of data is emerging about the involvement of
translational processes and factors in control of cell proliferation,
also indicating that protein synthesis can be an additional target
for anticancer strategies (Caraglia et al, 2000). In order to charac-
terise malignant melanoma cells, we had isolated and identiﬁed a
number of genes speciﬁcally regulated in human melanoma cells
as compared to normal human melanocytes (Eberle et al,
1995a,b, 1997, 1999). Within this group of genes, we identiﬁed
the translation initiation factor eIF-4A1 (Eberle et al, 1997), found
consistently upregulated at the mRNA level. As the oncogenic
potential of other translation initiation factors (e.g., eIF-4E and
eIF-2, had already been described in other cells; Lazaris-Karatzas
et al, 1990; Donze et al, 1995), we suggested that eIF-4A1 upregu-
lation may contribute speciﬁcally to the malignant phenotype of
melanoma. In the present paper, we addressed the question
whether we can confer inhibitory effects on melanoma cells by
obstructing eIF-4A1 gene expression using transient and stable
transfection of antisense constructs against eIF-4A1.
MATERIALS AND METHODS
Cell cultivation and transfection
Melanoma cell lines were maintained in DMEM (4.5 g l
71 glucose;
Gibco, Paisley, Scotland) supplemented with 10% foetal calf serum,
penicillin and streptomycin (Biochrom, Berlin, Germany). For cell
transfection, eight different lipids were tested (Pfx-1–Pfx-8; Invi-
trogen, Groningen, Netherlands), and for the subsequent
experiments, Pfx-2, which showed the best transfection efﬁciency
was consequently used. At a conﬂuence of 50%, cells were washed
in serum-free Opti-MEM (Gibco) and were incubated at 378Ci n
the same medium containing 0.5% Pfx-2 and 1.5 mgm l
71 plasmid
DNA. After 2 h, cells were washed once and were further incubated
with standard growth medium, which contained 2 mgm l
71 doxy-
cycline (ICN, Aurora, OH, USA) in case of induction. For stable
transfections, selective antibiotics, geneticin (Gibco; 400 mgm l
71)
or hygromycin (Boehringer, Mannheim, Germany; 100 mgm l
71),
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cells remained. Cell clones were obtained by limited dilution in
microtitre plates and were continuously cultured under antibiotic
pressure (geneticin and/or hygromycin).
Two tetracycline-inducible cell lines SKM13-Tet-On and Bro-
Tet-On were established from the cell lines Bro and SK-Mel-13
(Carey et al, 1976; Lockshin et al, 1985), respectively, by stable
transfection of the pTet-On plasmid (Clontech, Palo Alto, CA,
USA). The tetracycline-inducible gene expression system had been
described by Gossen and Bujard (1992). After stable transfection,
individual cell clones were screened for their tetracycline inducibil-
ity by transient transfection of the luciferase-encoding plasmid
pTRE-Luc (Clontech) followed by a luciferase assay (De Wet et
al, 1987; Promega, Madison, WI, USA), 48 h after transfection.
For promoter induction, doxycycline was used instead of tetracy-
cline as recommended by the supplier of the vector system
(Clontech). As a standard for the luciferase assay, puriﬁed lucifer-
ase (Promega; 3.3610
10 light units per mg protein) was used.
Double stable transfectants were obtained after transfection of
Bro-Tet-On with an eIF-4A1 antisense construct in pTRE-1 and
co-transfection with the hygromycin resistance plasmid pTK-Hyg
(1:20 molar ratio; both plasmids from Clontech).
Construction of antisense and control plasmids
Of the eIF-4A1 cDNA, which we had cloned earlier (Eberle et al,
1997), three different fragments from the 5' end, of the central
portion and from the 3' end, respectively, were subcloned by
restriction and ligation in antisense and in sense orientation, in
one or two copies, behind the tetracycline-inducible CMV promo-
ter present in the plasmid pTRE-1. Plasmid DNA used for cell
transfection was puriﬁed by an endotoxin-free plasmid puriﬁcation
kit (Birnboim and Doly, 1979; Qiagen, Hilden, Germany).
RNA extraction and Northern blotting
Cells were harvested at 70% conﬂuence, after adding fresh growth
medium 24 h before. Total RNA was isolated from trypsinised cells
using the RNeasy Mini Kit (MacDonald et al, 1987; Qiagen,
Hilden, Germany). For Northern blotting (Thomas, 1980), 10 mg
of total RNA per lane were separated in formaldehyde/agarose gels
(1.2% agarose). For determination of mRNA length, a 0.24–9.5 kb
RNA ladder (Gibco, Gaithersburg, TN, USA) was used. RNA was
transferred by capillary blotting to Gene Screen Plus membranes
(NEN Life Science, Cologne, Germany), and hybridisations were
carried out at 608C for 16 h. Probes for eIF-4A1 and b-actin
derived from a differential screening (Eberle et al, 1995a); the
cDNA fragments were radiolabelled by random priming (Gibco)
followed by puriﬁcation with Nuc-trap push columns (Stratagene,
La Jolla, CA, USA). Membranes were washed under stringent
conditions (45 min at 658Ci n2 6 sodium citrate buffer, SSC)
and were then exposed to an imaging plate for quantiﬁcation of
radioactivity by a BAS-1500 Phosphoimager (Fuji, Nakanuma,
Japan). For reasons of normalisation, membranes were boiled in
water and rehybridised with a probe for b-actin. Quantiﬁed indivi-
dual expression values were ﬁrst normalised by corresponding b-
actin values and then compared with each other.
Determination of cell proliferation and cell number
Cell proliferation was determined by the thymidine incorporation
assay (O’Keefe et al, 1988). Cells were seeded in 96-well plates
and were transiently transfected with a given plasmid construct
(60 wells of a microtitre plate corresponded to one transfection
experiment, wells of the margin were only ﬁlled with growth
medium). For induction, doxycycline was added to every second
well. Two days after transfection, wells were washed once with
growth medium, and cells were incubated in growth medium
containing
3H-thymidine (2.5 mCi ml
71; 68.5 Ci mmol
71) for
2 h. After harvesting the cells with a cell harvester, tritium incor-
poration was measured in a scintillation counter. Ratios of each
two neighbouring wells (induced versus non-induced) were deter-
mined and a mean value (induced versus non-induced) was
calculated for each microtitre plate. At least three independent
experiments (three microtitre plates) were performed for each
combination of cell line and plasmid construct, and ﬁnally mean
values and standard deviations were calculated from individual
experiments.
Comparison of proliferation of stably transfected cell clones was
performed in a similar way, only no transient transfection was
needed, and cells were harvested 2 days after induction with doxy-
cycline. Also here, one experiment corresponded to one microtiter
plate and at least three independent experiments were performed
for each cell line.
Cell numbers were determined 2 days after transient transfection
either by direct cell counting in a Neubauer chamber or by the
crystal violet assay described by Gillies et al (1986). In brief, cells
grown in six-wells were ﬁxed for 30 min with 1% glutaraldehyde
and stained for another 30 min in a 0.01% crystal violet solution
in PBS. Plates were washed in deionised water for 30 min, and
were then completely dried. Crystal violet absorbed by cell nuclei
was solubilised with 0.2% Triton X-100 in PBS. Aliquots were
measured in an ELISA-Reader at 550 nm.
Statistical analysis
For statistical analysis, the individual values (single wells) of an
experiment were normalised by the mean value of the respective
experiment. Thus, values of independent experiments could be
combined in groups and resulted in an induced (+) group and a
not induced (7) group. To demonstrate statistical signiﬁcance of
inhibition of cell proliferation or reduced cell numbers due to
induction of antisense constructs, Student’s t-test was applied
(unpaired and heteroscedastic).
RESULTS
Establishment of Tet-On melanoma cell lines
As a prerequisite for applying the tetracycline-regulated gene
expression system described by Gossen and Bujard (1992) for
melanoma cells, we prepared suitable Tet-On cell lines by stable
transfection of the pTet-On plasmid into the undifferentiated
and amelanotic melanoma cell line Bro as well as into the differ-
entiated melanoma cell line SK-Mel-13 characterised both by
dendrite and melanin formation. After transfection, several genet-
icin-resistant cell clones were isolated, which were subsequently
screened for their doxycycline inducibility using a luciferase repor-
ter plasmid. One clone of each transfection was selected which
showed the highest doxycycline inducibility: Bro-Tet-On and
SKM13-Tet-On.
In order to optimise transient melanoma cell transfection, a
series of different lipids and conditions were tested. The use of
different lipids resulted in dramatic differences in transfection efﬁ-
ciency of more than 200-fold; responses of both melanoma cell
lines to different lipids were in parallel (data not shown). Thus,
optimisation of transfection conditions for a certain cell type
seemed to be absolutely required. Luciferase activity obtained by
the improved transfection protocol (see Materials and Methods)
and after doxycycline induction was equivalent to 7610
6 enzyme
units per 10
6 Bro-Tet-On cells, and to 3610
6 units per 10
6
SKM13-Tet-On cells, respectively, what was more than 1000-fold
over background (untransfected cells). The induction factors
resulted from doxycycline treatment as compared to non-induced
cell cultures were 22+6 (Bro-Tet-On) and 28+9 for SKM13-
Tet-On, respectively.
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For expression of antisense-RNA directed against the translation
initiation factor eIF-4A1, three different cDNA fragments, from
the cDNA 5'-end, of the central portion and from the 3'-end, were
subcloned in antisense orientation into a tetracycline responsive
expression plasmid downstream of the tetracycline-inducible
promoter. For answering the question whether a higher copy
number may be critical for an antisense effect, the central-fragment
was also subcloned in tandem in antisense orientation. As negative
controls, the central-fragment was subcloned as one and as two
tandem copies in sense orientation (Table 1).
For investigating the expression and inducibility of correspond-
ing RNAs, cells were transiently transfected with the plasmid
constructs, and doxycycline induced cells were compared 2 days
later with non-induced cells, at the RNA level. As demonstrated
in Figure 1, speciﬁc RNA expression was found after transient
transfection for all plasmids constructed. After doxycycline induc-
tion, a strong increase of all plasmid-encoded RNAs was visible
in both cell lines when compared to cultures grown without doxy-
cycline. The steady state concentrations of endogeneous eIF-4A1
mRNA were difﬁcult to quantify due to the high background of
construct-speciﬁc RNA after transient transfection, but were not
signiﬁcantly reduced for any of the constructs, two days after trans-
fection and induction (data not shown).
Antiproliferative effects caused by antisense constructs
against eIF-4A1, after transient transfection and induction
of antisense constructs
As translation efﬁciency may be a critical checkpoint for cell prolif-
eration, we determined cell proliferation rates after transient
transfection and compared cells induced with doxycycline versus
cells grown without. As shown in Figure 2, thymidine incorpora-
tion rates in cells transiently transfected with three antisense
constructs were signiﬁcantly reduced after doxycycline induction.
Relative proliferation rates for induced Bro-Tet-On cells as
compared to non-induced cells were at 90.4+2.5% after transfec-
tion of antisense-2x-central, 92.6+3.8% for antisense-central, and
90.8+4.6% for antisense-5'-end (Figure 2A). The antiproliferative
antisense effects observed for SKM13-Tet-On after induction were
largely in parallel: 89.8+4.3% for antisense-2x-central, 90.6+7.1%
for antisense-central, and 93.9+2.6% for antisense-5'-end (Figure
2B). As each experiment consisted of 60 individually counted wells
and was repeated at least three times, values were statistically
signiﬁcant (P-values see legend of Figure 2).
No antiproliferative effect, however, was seen for both of the
sense controls (sense-central and sense-2x-central) as well as for a
luciferase-encoding plasmid used as an additional control. Also,
no antiproliferative effect was seen for the antisense construct
directed against the 3'-end (antisense-3'-end) for any of both cell
lines. As can be concluded from the comparison of the effects
caused by antisense-central versus antisense-2x-central, doubling of
the copy number was not able to signiﬁcantly increase the antipro-
liferative effect (Figure 2).
Also, cell numbers were determined after transient transfection
of AS-2x-central as compared to sense-2x-central in SKM13-Tet-
On and Bro-Tet-On. Signiﬁcantly reduced cell numbers were found
2 days after induction of antisense RNA, comparable to the results
obtained by the tritium thymidine incorporation assay (Table 2).
Reduced proliferation in stable transfected melanoma cell
lines after induction of antisense constructs
To investigate whether the antiproliferative effect is retained after
stable transfection, when smaller amounts of antisense-RNA have
to be expected than after transient transfection, we stably transfected
the melanoma cell line Bro-Tet-On with antisense-2x-central. In the
following, ﬁve individual hygromycin-resistant cell clones were
analysed. We ﬁrst looked for eIF-4A1-speciﬁc RNA in the trans-
fected cell clones, after doxycycline induction: No detectable levels
of antisense RNA were found after Northern analysis, however,
quantiﬁcation of the endogeneous sense mRNA for eIF-4A1
(1850 N and 1550 N) revealed a decrease 2 days after doxycycline
induction in all of the ﬁve clones, whereas the parent cell line,
Bro-Tet-On, did not respond to doxycycline (Figures 3A and 4).
Proliferation assays revealed for three of the ﬁve clones signiﬁ-
cantly reduced proliferation rates after doxycycline induction as
compared to non-induced cells, whereas, the parent cell line Bro-
Tet-On did not show a proliferation decrease (Figure 3B).
DISCUSSION
Gene expression in eucaryotes is regulated at several levels including
the level of mRNA translation. In the last years, a series of reviews
has been published on translational control giving a high impact
on its role in cell growth and tumorigenesis (Clemens and Bommer,
1999; Jagus et al, 1999; Willis, 1999; Caraglia et al, 2000; Zimmer et
al, 2000). Translational control no longer appears as a general and
unselective control mechanism, but an increasing number of
proteins were identiﬁed which are selectively regulated and which
are involved in control of cell cycle and proliferation. Initiation of
protein synthesis turned out as the rate-limiting step in translational
control with particular attention being paid to expression and acti-
vation of eIF-2a and eIF-4E, which are activated and inactivated by
phosphorylation, respectively (Jagus et al, 1999; Zimmer et al, 2000).
A relation between translational control and malignant cell
transformation became obvious, when elevated levels of eIF-4E as
well as reduced levels of the eIF-2a kinase, PKR, were detected
in cancer cells (Kerekatte et al, 1995; Nathan et al, 1997; Jagus et
al, 1999). Furthermore, overexpression of eIF-4E induced transfor-
mation (Rhoads, 1993), and its inhibition by antisense RNA
decreased the malignancy of transformed cells (Graff et al, 1995).
The oncogenic potential of eIF-2a was demonstrated by inhibition
of its phosphorylation (Jagus et al, 1999). These ﬁndings on eIF-4E,
eIF-2a and their kinases have resulted in the deﬁnition of a new
group of translational oncogenes. Only limited data were available
about the expression of translation factors in melanoma as well
as about the role of eIF-4A1 in tumorigenesis. In a previous study,
we reported consistent upregulation of eIF-4A1 mRNA in melanoma
cell lines, as compared to normal human melanocytes, which led us
suggest that eIF-4A1 may be related to melanoma cell transforma-
tion (Eberle et al, 1997).
Antisense techniques are powerful strategies to act against the
malignant potential of genes upregulated in cancer. Having a phar-
maceutical approach in mind, preferentially antisense
oligonucleotides have been tested for their usefulness in cancer
therapy. For an antisense-based, gene therapeutic approach,
however, viral vectors and antisense RNA expression are needed.
For melanoma, clinical studies using antisense oligonucleotides
against the antiapoptotic Bcl-2 are on the way aiming the sensitisa-
tion of tumour cells against chemotherapy (Jansen et al, 2000).
Several other genes were targeted in melanoma cells by in vitro
studies, as the anti-apoptotic factor survivin (Grossman et al,
1999), the transcription factor c-myc (Citro et al, 1998) and the
growth factor pleiotrophin (Satyamoorthy et al, 2000).
In the present study, we investigated whether eIF-4A1 can be
targeted in cultured melanoma cells by overexpression of antisense
RNA using antisense plasmid constructs. In order to reach high
comparability, we established the tetracycline-regulated expression
system in human melanoma cell lines, which allowed the direct
comparison between induced and non-induced cells; also relatively
weak differences could be quantiﬁed this way. Signiﬁcant antipro-
liferative effects were found after induction of three different eIF-
4A1 antisense constructs, both after transient and after stable trans-
fection. The only limited antiproliferative effect which was obtained
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seen in relation to the relatively high expression of eIF-4A1 mRNA
in melanoma cells, comparable to the expression of major proteins
as glycolytic enzymes and b-tubulin (Eberle et al, 1995a).
Due to the experience with antisense oligonucleotides, it is
generally assumed that antisense can either result in reduction of
the targeted mRNA due to speciﬁc ribonucleases or in direct
obstruction of translation (Crooke, 1999). After stable transfection,
we observed reduction of eIF-4A1 steady state RNA level, whereas
this was not seen after transient transfection indicating that reduc-
tion of mRNA was not necessary in these experiments for
obtaining the antiproliferative effect. Doubling of the copy number
by using a tandem repeat of an antisense fragment did not further
enhance the antisense effect, possibly indicating that a saturation
point was already reached. Experience with antisense oligonucleo-
tides had also shown that the effect of a given oligonucleotide is
strongly dependent on the particular sequence targeted (Dean et
al, 1994). This was also true in our approach, where we found
comparable effects for a 5' fragment and a central fragment
whereas a 3' fragment did not result in any proliferation effect.
The data presented here demonstrate that human melanoma cells
can be targeted by antisense constructs, even when the targeted
mRNA is strongly expressed as in the case of eIF-4A1.
Due to a sequence comparison of translationally controlled
mRNA species, it was predicted that many proliferation-related
proteins will be regulated at the translational level (Kozak, 1991).
The predicted secondary structures in their 5' untranslated regions
seem to be inhibitory for the ribosomal scanning process resulting
in a dependence on the unwinding machinery (Sonenberg, 1996),
which is based in particular on RNA helicase activity of eIF-4A1.
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Table 1 Antisense and control plasmids used against eIF-4A1
pTRE constructs
a 5' end
b 3' end
b Copies Orientation cDNA
c RNA
d
AS-5'-end 46 304 1 anti 258 400
AS-3'-end 841 1451 1 anti 610 1000
AS-central 304 600 1 anti 304 450
AS-2x-central 304 600 2 anti/anti 608 900
Sense-central 304 600 1 sense 304 450
Sense-2x-central 304 600 2 sense/sense 608 900
aFour antisense (AS) constructs of eIF-4A1 fragments and two sense controls were established in the
expression plasmid pTRE.
bPositions of 5'- and 3'-ends of the fragments, used, are given in respect to
the ATG and in accordance to the published sequence of eIF-4A1 cDNA coding region (Kim et al,
1993) and extended 3' end (Eberle et al, 1997).
cLength of the subcloned cDNA fragments.
dLength of
the resulting RNA as determined by Northern blotting.
AS-3´
end
AS-5´
end
AS
central
AS-2x
central
Sense-2x
central
Sense
central
–      +       –       +       –       +       –       +       –       +       –       +
1850
1550
1000
900
450
400
1800
1850
1550
1000
900
450
400
1800
A
B
C
D
Figure 1 Expression of antisense RNA. Northern blots are shown of the
cell lines SKM13-Tet-On (A and B) and of Bro-Tet-On (C and D). Total
RNA was extracted 2 days after transient transfection of six different anti-
sense and sense constructs for translation initiation factor eIF-4A1 sub-
cloned behind a tetracycline-inducible promoter (names of constructs
are given in the top). Cell cultures grown with doxycycline (+) were com-
pared with cultures grown without doxycycline (7). Northern blots were
hybridised with cDNA probes speciﬁc for eIF-4A1 (A and C) and for b-
actin (B and D), respectively. The position and length of the endogeneous
mRNAs for eIF-4A1 (1850 N and 1550 N), of b-actin (1800 N), and of
the different plasmid-derived RNAs is indicated at the left margin.
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end
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Sense
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Sense-2x
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Luc
AS-2x
central
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central
AS-5'
end
AS-3'
end
Sense
central
Sense-2x
central
pTRE
Luc
Bro-Tet-On
SKM13-Tet-On
Figure 2 Reduced proliferation after transient transfection. Cell lines
Bro-Tet-On (A) and SKM13-Tet-On (B) were transiently transfected with
four antisense constructs (AS), two sense controls and the luciferase-en-
coding plasmid pTRE-Luc used as an additional control. Proliferation rates
were determined in microtiter plates two days after transfection and induc-
tion with doxycycline. Relative proliferation rates were calculated as the ra-
tio between cultures induced with doxycycline versus non-induced cultures
(in %), and bars represent deviations from 100%. Each of the bars corre-
sponds to mean values of at least three independent experiments of each
60 counted wells (180 wells). Signiﬁcant reduction of proliferation is indi-
cated by asterisks. According to Student’s t-test, P-values for Bro-Tet-On
were 50.0001 (AS-2x-central), 50.005 (AS-central), 50.0002 (AS-5'-
end); P-values for SKM13-Tet-On were 50.0001 (AS-2x-central),
50.0001 (AS-central), 50.02 (AS-5'-end).
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factors and cytokines (Nielsen et al, 1995; Vagner et al, 1995; Bern-
stein et al, 1997). Furthermore, translational control has been
shown for the cell cycle regulator cyclin D1 (Rosenwald et al,
1993), the transcription factor c-myc (Nanbru et al, 1997), several
protein kinases (Marth et al, 1988; Yew et al, 1993) as well as for
the key enzymes of polyamine synthesis which is closely linked to
cell proliferation (Ruan et al, 1996). Therefore, the signiﬁcance of
translational control for cell proliferation became obvious. Further-
more, the oncogenic potential of several translationally regulated
genes has been reported. In agreement, we found signiﬁcant anti-
proliferative effects after induction of antisense RNA against eIF-
4A1, strongly suggesting that in human melanoma cells, eIF-4A
plays at least an auxiliary role in regulation of cellular proliferation.
This assumption is further promoted by the ﬁnding that only eIF-
4A1 but none of the other group 4 translation factors (eIF-4E, eIF-
4B, eIF-4G, eIF-4A2) was signiﬁcantly upregulated in melanoma
cells as compared to normal melanocytes (Eberle et al, 1997).
In conclusion, our data underline the role of translation factors
for cell proliferation and support the concept of translational onco-
genes. Recent studies have focussed on the role of the factors eIF-
4E and eIF-2a in malignant cell transformation; no data were avail-
able on melanoma cells. Our data suggest that a concerted action
of several translation factors, including eIF-4A1, may be decisive
for the translational contribution to melanoma development. It is
likely that future therapeutic strategies will simultaneously target
several genes also including the translational level. Due to the
rather limited growth effect obtained after stable transfection, anti-
sense gene therapies exclusively against eIF-4A1 would be not
sufﬁcient in melanoma, however, they may be contributory and
helpful in combination with other gene targets.
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SKM13-Tet-On sense-2x-central 0.98 0.04
SKM13-Tet-On AS-2x-central 0.93 0.03 50.001
aTwo Tet-On melanoma cell lines were transiently transfected with the antisense
construct AS-2x-central and with the sense control, respectively.
bCell numbers
were determined for doxycycline-induced cells (+), by crystal violet assay, and were
compared to non induced cells (7), the ratio (+/7) is given here.
cStatistical signifi-
cance of reduced cell numbers after doxycycline induction in antisense-transfected
cells was determined by unpaired Student’s t-test.
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499-22      499-31    499-32    499-41      499-62  Bro-Tet-On
B
499-22      499-31    499-32   499-41    499-6    Bro-Tet-On
*
*
*
A
Figure 3 Reduced proliferation after induction of AS-2x-central in stably
transfected cell clones. The cell line Bro-Tet-On was stably transfected with
the antisense construct AS-2x-central. Five individual cell clones (499) as
well as the parent cell line Bro-Tet-On were analysed 2 days after induction
with doxycycline. (A) Amount of endogeneous mRNA for eIF-4A1, as de-
termined by Northern blotting, densitometry and normalisation with b-ac-
tin mRNA (median values of two independent experiments). (B) Relative
proliferation rates were calculated as the ratio between cultures induced
with doxycycline versus non-induced cultures (in %), and the bars represent
deviations from 100%. Each of the bars corresponds to mean values of at
least three independent experiments of each 60 counted wells (180 wells).
Signiﬁcant reduction of proliferation is indicated by asterisks. According to
Student’s t-test, P-values were 50.03 (499-22), 50.02 (499-41), 50.002
(499-62).
+        –        –        +        –        +        –        +       +        –
499-32           499-22           499-41          499-62            499-31
elF4A1
b-actin
Figure 4 Reduced eIF-4A1 mRNA amounts after induction of AS-2x-
central in stably transfected cell clones. The Tet-On cell line Bro-Tet-On
was stably transfected with the antisense construct AS-2x-central. Amounts
of eIF-4A1 mRNA were determined by Northern blotting after induction
(+) and without induction (7) with doxycycline in ﬁve individual cell clones
(499-). Expression levels for b-actin were analysed in parallel and were
used for normalisation.
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